EQUILLIUM, INC.

EQ ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $30.3M $18.1M $23.2M $59.1M $50.4M $24.0M $13.2M $28.5M
Accounts Receivable $0 $3.7M $2.8M $0
Inventory
Total Current Assets $31.0M $25.0M $49.3M $76.7M $83.4M $85.2M $55.4M $67.1M
Property, Plant & Equipment $164.0K $262.0K $315.0K $391.0K $237.0K $239.0K $93.0K $64.0K
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $31.9M $25.6M $50.5M $78.4M $85.4M $85.4M $55.5M $67.2M
Liabilities
Accounts Payable $755.0K $2.7M $4.7M $4.0M $1.2M $2.8M $1.9M $1.1M
Total Current Liabilities $2.9M $6.4M $27.6M $32.0M $8.9M $7.2M $3.9M $2.0M
Long-Term Debt $3.2M $8.8M $8.3M $9.7M
Total Liabilities $3.3M $6.5M $28.0M $46.5M $18.9M $15.6M $13.7M $2.2M
Stockholders' Equity
Retained Earnings $-216.2M $-193.8M $-185.7M $-172.4M $-110.0M $-70.9M $-41.1M $-15.5M
Total Stockholders' Equity $28.6M $19.1M $22.6M $31.9M $66.5M $69.9M $41.8M $64.9M
← Newer Page 1 of 2 Older →